Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

BIOMARKER:

MYC overexpression + IDH1 mutation

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

‹

IDH1 mutation (79)

MYC rearrangement + BCL2 rearrangement (22)

MYC rearrangement + BCL6 rearrangement (9)

MYC rearrangement (7)

MYC rearrangement + BCL2 rearrangement + BCL6 rearrangement (6)

MYC mutation (5)

MYC translocation (4)

MYC translocation + BCL2 translocation (3)

IDH wild-type (3)

FLT3-ITD mutation + IDH1 mutation (2)

IDH1 wild-type + BRAF mutation (2)

IDH1 wild-type + NF1 mutation (2)

EGFR exon 19 deletion + ATM S1455fs*36 + MYC E62K (1)

MYC translocation + BCL6 translocation (1)

MYC translocation + BCL6 translocation + BCL2 translocation (1)

DNMT3A mutation + IDH mutation (1)

EGFR L858R + IDH1 R132C (1)

EGFR mutation + IDH1 mutation (1)

EGFR mutation+ IDH1 R132H (1)

FLT3 mutation + IDH1 mutation (1)

IDH1 R132C + EGFR L861Q (1)

IDH1 R132C + IDH1 S280F (1)

IDH1 R132C + PIK3CA E545K + IDH2 R172K (1)

IDH1 R132H + PTEN C78T (1)

IDH1 mutation + TP53 mutation (1)

IDH1 rs1437410 (1)

MYC rearrangement + BCL2 rearrangement+ BCL6 rearrangement (0)

IDH mutation + BRAF V600E (0)

IDH mutation + Chr del(1p) + Chr del(19q) (0)

IDH mutation + Chr del(1p) + Chr del(19q) + BRAF V600E (0)

IDH mutation + Chr del(1p) + Chr del(19q) + NTRK fusion (0)

IDH mutation + NTRK fusion (0)

IDH1 mutation (79)

MYC rearrangement + BCL2 rearrangement (22)

MYC rearrangement + BCL6 rearrangement (9)

MYC rearrangement (7)

MYC rearrangement + BCL2 rearrangement + BCL6 rearrangement (6)

MYC mutation (5)

MYC translocation (4)

MYC translocation + BCL2 translocation (3)

IDH wild-type (3)

FLT3-ITD mutation + IDH1 mutation (2)

IDH1 wild-type + BRAF mutation (2)

IDH1 wild-type + NF1 mutation (2)

EGFR exon 19 deletion + ATM S1455fs*36 + MYC E62K (1)

MYC translocation + BCL6 translocation (1)

MYC translocation + BCL6 translocation + BCL2 translocation (1)

DNMT3A mutation + IDH mutation (1)

EGFR L858R + IDH1 R132C (1)

EGFR mutation + IDH1 mutation (1)

EGFR mutation+ IDH1 R132H (1)

FLT3 mutation + IDH1 mutation (1)

IDH1 R132C + EGFR L861Q (1)

IDH1 R132C + IDH1 S280F (1)

IDH1 R132C + PIK3CA E545K + IDH2 R172K (1)

IDH1 R132H + PTEN C78T (1)

IDH1 mutation + TP53 mutation (1)

IDH1 rs1437410 (1)

MYC rearrangement + BCL2 rearrangement+ BCL6 rearrangement (0)

IDH mutation + BRAF V600E (0)

IDH mutation + Chr del(1p) + Chr del(19q) (0)

IDH mutation + Chr del(1p) + Chr del(19q) + BRAF V600E (0)

IDH mutation + Chr del(1p) + Chr del(19q) + NTRK fusion (0)

IDH mutation + NTRK fusion (0)

›

MYC overexpression + IDH1 mutation	Acute Myelogenous Leukemia	MYC overexpression + IDH1 mutation	Acute Myelogenous Leukemia	enasidenib Resistant: C3 – Early Trials enasidenib Resistant : C3	enasidenib Resistant: C3 – Early Trials enasidenib Resistant : C3
MYC overexpression + IDH1 mutation	Acute Myelogenous Leukemia	MYC overexpression + IDH1 mutation	Acute Myelogenous Leukemia	ivosidenib Resistant: C3 – Early Trials ivosidenib Resistant : C3	ivosidenib Resistant: C3 – Early Trials ivosidenib Resistant : C3